Fortrea

Accelerating Oncology - Inside the EPON Network

Health EN ↓ Odcinki: 3

We take you inside Fortrea’s EPON model, where early phase innovation meets operational excellence. Through conversations with medical leaders, investigators, and site engagement experts, we unpack how specialized site models, strategic geography, and deep scientific collaboration accelerate first in human and early phase oncology studies.

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: async.com

Autor

Fortrea

Kategoria

Health

Strona podcastu

async.com

Ostatni odcinek

15 kwi 2026

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Zainstaluj za darmo Android 5 mln+ pobrań · ocena 4,8 iOS niedługo

Odcinki

Inside the EPON Network | Ep 3 | Why Location Matters: Country Site Placement Strategy 15.04.2026 11:41

In this episode, we explore why geography is more than a backdrop—it is a strategic lever in early phase oncology trials. From patient access and regulatory timelines to investigator expertise and data governance, every decision about trial placement can accelerate or stall innovation. Join host Maria Garcia and Ken Morrison, as they unpack how Fortrea’s EPON Network optimizes site selection to de...

Inside the EPON Network | Ep 2 | How EPON Builds Strong Site Partnerships 15.04.2026 13:59

In this episode of Accelerating Oncology – Inside the EPON Network, host Maria Garcia discusses why partnerships matter in early phase oncology. We’ll also find out what makes an EPON site different and talk about partnership design principles. Host: María García Requesens, Medical Director Fortrea Participants: Dr. William McKean, Medical Oncologist and Principal Investigator at The START Center...

Inside the EPON Network | Ep 1 | What EPON Really Means: Accelerating Excellence in Early Phase Oncology 15.04.2026 7:44

Early Phase Oncology trials have evolved from simple safety checks to the most scientifically demanding stage of cancer drug development. In this episode of Accelerating Oncology – Inside the EPON Network, host Ken Morrison and guest María García unpack why Phase 1 trials are no longer “entry-level” and why they require a specialized model for success.